APA (7th ed.) Citation

AS, A., L, V., R, S., RD, A., C, R., S, O., . . . R, J. (2024). Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review. Journal of cardiovascular development and disease, 11(2), . https://doi.org/10.3390/jcdd11020041

Chicago Style (17th ed.) Citation

AS, Afana, Vasiliu L, Sascău R, Adam RD, Rădulescu C, Onciul S, Cinteză E, Chirita-Emandi A, and Jurcuț R. "Phospholamban P.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review." Journal of Cardiovascular Development and Disease 11, no. 2 (2024). https://doi.org/10.3390/jcdd11020041.

MLA (9th ed.) Citation

AS, Afana, et al. "Phospholamban P.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review." Journal of Cardiovascular Development and Disease, vol. 11, no. 2, 2024, https://doi.org/10.3390/jcdd11020041.